Skip to main content
. 2022 Jan-Feb;38(1):179–184. doi: 10.12669/pjms.38.1.4419

Table I.

Pre-treatment clinical data.

Group Number of Patients Sex Age Course of Disease Number of Cavities Involved Lung Field(s) Sputum AFB Grades

n Male Female (years) (months) 1-4 ≥4 1+ 2+ 3+ 4+
Tα1 60 36 24 46.68±9.44 6.85±2.78 56 26 34 10 24 20 6
Control 60 40 20 47.53±9.62 6.77±2.12 54 22 38 12 18 22 8
X2/t 0.287 0.345 0.125 0.000 0.281 0.111 0.660 0.071 0.001
P >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05